Latest research on Haloperidol

A phenyl-piperidinyl-butyrophenone that is used primarily to treat schizophrenia and other psychoses. It is also used in schizoaffective disorder, delusional disorders, ballism, and tourette syndrome (a drug of choice) and occasionally as adjunctive therapy in mental retardation and the chorea of huntington disease. It is a potent antiemetic and is used in the treatment of intractable hiccups. (From AMA Drug Evaluations Annual, 1994, p279)

Latest findings

Weight bearing was determined using an incapacitance tester (Linton Instrumentation, Diss, UK; [28]). [source, 2016]
A beam break rig (Linton Instrumentation, UK) was used to assess the locomotor activity of mice. [source, 2016]
An automated data logging suite (AMON Lite, Linton Instrumentation, UK) was used to track the movement of mice throughout the experimental session. [source, 2016]
In addition, sulpirides have fewer extrapyramidal effects than other typical antipsychotics such as Haloperidol [1]. [source, 2016]
Lai et al. [11] have shown, using pragmatic outcome measures, that the effectiveness of sulpiride was better than Haloperidol and Risperidone. [source, 2016]
Commensurate with this hypothesis, systemic administration in humans of the Dopamine precursor L-DOPA increases discount rates (Pine et al., 2010), although potentially countervailing evidence is that decreasing Dopamine transmission in rats by administration of Haloperidol (Denk et al., 2005) or flupethixol (Floresco et al., 2008) has been found to increase discounting, or in other studies to exert no significant effect on discounting (Winstanley et al., 2005). [source, 2016]
A von Frey filament with a bending force of 0.4 g (Linton Instrumentation, Norfolk, UK) was applied to the mid plantar skin of each hind paw 10 times, with each application held for 3 s [54]. [source, 2016]
In terms of drug treatments, use of Haloperidol, Clozapine, Quetiapine and Aripiprazole was more frequent in patients treated with AP polypharmacy (Table 1). [source, 2016]
We tested whether Haloperidol and individual second-generation AP drugs were associated with QTc lengthening (Table 2), controlling for AP polypharmacy and dose. [source, 2016]
Risk associated with Haloperidol and individual second-generation AP drugs provided additional clinically interesting insights. [source, 2016]